CVA Family Office’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.62K Sell
168
-124
-42% -$4.07K ﹤0.01% 1297
2026
Q1
$10.9K Buy
292
+191
+189% +$7.87K ﹤0.01% 963
2025
Q4
$4.72K Hold
101
– – ﹤0.01% 895
2025
Q3
$4.23K Hold
101
– – ﹤0.01% 914
2025
Q2
$4.45K Hold
101
– – ﹤0.01% 906
2025
Q1
$5.09K Hold
101
– – ﹤0.01% 893
2024
Q4
$4.34K Hold
101
– – ﹤0.01% 894
2024
Q3
$3.96K Hold
101
– – ﹤0.01% 882
2024
Q2
$3.25K Buy
+101
New +$3.26K ﹤0.01% 889
2022
Q3
– Sell
-30
Closed -$1K – 891
2022
Q2
$1K Hold
30
– – ﹤0.01% 866
2022
Q1
$1K Buy
+30
New +$1.39K ﹤0.01% 919

Other funds holding G

CVA Family Office's G Position: Q2 2026 in Review

CVA Family Office reduced its Genpact (G) stake by 42% in Q2 2026, selling an estimated $4.07K and leaving 168 shares worth $4.62K. The position accounts for ﹤0.01% of the portfolio, ranked #1297.

CVA Family Office first reported a position in G in Q1 2022 and has held it in 11 quarters since. The position peaked at $10.9K in Q1 2026. 479 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • CVA Family Office held 168 shares of Genpact worth $4.62K as of Q2 2026.
  • CVA Family Office sold 124 Genpact shares in Q2 2026, an estimated $4.07K.
  • Genpact made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1297 holding.
  • CVA Family Office first reported a position in Genpact in Q1 2022 and has held it in 11 quarters since.
  • CVA Family Office's Genpact position peaked at $10.9K in Q1 2026.
  • 479 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.